LAG3 and neoplasm: LAG-3, another novel checkpoint, is expressed on effector T cells, Tregs, and DCs, and the evidence indicates that the upregulation of both PD-1 and LAG-3 leads to T cell exhaustion and tolerance to tumor antigens [42].